
European Medicines Agency Accepts Tofersen Marketing Authorization Application to Treat Rare, Genetic Form of ALS
European Medicines Agency Accepts Tofersen Marketing Authorization Application to Treat Rare, Genetic Form of ALS Biogen Inc. (Nasdaq: BIIB) announced the European Medicines Agency (EMA) has…